Aster Capital Management DIFC Ltd Makes New Investment in iShares Biotechnology ETF $IBB

Aster Capital Management DIFC Ltd bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 13,210 shares of the financial services provider’s stock, valued at approximately $1,907,000. iShares Biotechnology ETF comprises approximately 1.0% of Aster Capital Management DIFC Ltd’s portfolio, making the stock its 14th largest holding.

A number of other large investors also recently made changes to their positions in the stock. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the second quarter worth $25,000. Financial Gravity Companies Inc. acquired a new position in iShares Biotechnology ETF in the second quarter valued at about $29,000. Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF during the third quarter worth about $36,000. Parkside Financial Bank & Trust grew its position in shares of iShares Biotechnology ETF by 48.6% during the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after buying an additional 87 shares during the period. Finally, Close Asset Management Ltd grew its position in shares of iShares Biotechnology ETF by 25.5% during the 3rd quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after buying an additional 70 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.8%

Shares of IBB stock opened at $173.88 on Friday. The stock has a 50-day moving average of $172.77 and a 200-day moving average of $159.84. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were issued a $0.1831 dividend. This represents a $0.73 annualized dividend and a yield of 0.4%. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date was Tuesday, December 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.